Aldeyra Therapeutics, Inc. Share Price
ALDXAldeyra Therapeutics, Inc. Stock Performance
Open $4.29 | Prev. Close $4.12 | Circuit Range N/A |
Day Range $4.03 - $4.30 | Year Range $1.18 - $7.15 | Volume 67,539 |
Average Traded $4.12 |
Aldeyra Therapeutics, Inc. Share Price Chart
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Aldeyra Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Jan-26 | $4.29 | $4.07 | +0.00% |
06-Jan-26 | $4.29 | $4.07 | -4.13% |
05-Jan-26 | $4.60 | $4.24 | -9.11% |
02-Jan-26 | $5.08 | $4.67 | -9.94% |
31-Dec-25 | $5.14 | $5.18 | +0.58% |
30-Dec-25 | $5.15 | $5.15 | -0.39% |
29-Dec-25 | $5.26 | $5.17 | -2.73% |
FAQs on Aldeyra Therapeutics, Inc. Share Price
Can I buy Aldeyra Therapeutics, Inc. shares in India?
What is the share price of Aldeyra Therapeutics, Inc.?
What is the 5 year returns of Aldeyra Therapeutics, Inc.?
What are the high & low stock price of Aldeyra Therapeutics, Inc. today?
What is the 52-week high and low of Aldeyra Therapeutics, Inc. stock?